|THRX -- USA Stock|| |
null 9.81 9.81 9,223,372,036,855%
Mr. Michael W. Aguiar serves as President Chief Executive Officer Director of Theravance Inc. effective August 15 2014. He was appointed President and Chief Executive Officer of Innoviva Inc. and became a member of our Board of Directors in August 2014. He joined Innoviva as Senior Vice President and Chief Financial Officer in March 2005. Prior to joining Innoviva Mr. Aguiar served as Vice President of Finance at Gilead Sciences Inc. a biopharmaceutical company since 2002. Prior to Gilead Sciences Inc. Mr. Aguiar served as Vice President of Finance at Immunex Corporationrationration a biopharmaceutical company from 2001 to 2002. From 1995 to 2001 he was with Honeywell International in a variety of positions including most recently CFO and Vice President Finance for Honeywell Electronic Materials SBU. Mr. Aguiar earned a B.S. in biology from the University of California Irvine and an M.B.A. in finance from the University of Michigan. Mr. Aguiar demonstrated leadership in his field his prior senior management experience in our industry and his experience as our Chief Executive Officer and as our former Chief Financial Officer contributed to our conclusion that he should serve as a director.
Age: 48 CEO Since 2014 MBA
Aguiar earned a B.S. in Biology from UC Irvine and an M.B.A. in Finance from the University of Michigan.